Company intelligence / Profile preview

Zendal Group

O Porriño, Pontevedra, Spainzendal.com ↗
Ownership
Private
Employees
~650
Development stage
Phase 3
01

Overview

Zendal Group has established itself as a leader in the development and manufacture of biological products—especially vaccines—for both human and animal health. Its subsidiary Biofabri leads the industrial production of COVID antigens for Europe. The group’s TB vaccine candidate MTBVAC has entered large-scale clinical trials with international partners. The company also recently launched the first DNA-based canine leishmaniasis vaccine and commercialized Europe’s first EHD vaccine.

Therapeutic areas
NeurologyInfectious Diseases
Modalities
Vaccines (including DNA vaccines)Biodrugs/biologicalsPossibly others via subsidiaries (e.g., probiotics)
Industry
Biotech
02

Drug pipeline

1 asset

MTBVAC

Phase 3
Indications
Tuberculosis
03

Partnerships

IAVI (International AIDS Vaccine Initiative)—TB vaccine clinical development/funding partnership.Bharat Biotech—partnership/licensing agreement for global rollout of MTBVAC TB vaccine.European Health & Digital Executive Agency/TBVI—for final development acceleration of MTBVAC.

Beyond the preview

Go deeper on Zendal Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zendal Group.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call